Browsing: GLP-1 receptor agonists

Holiday seasons present unique challenges for individuals managing diabetes or weight-loss through medication. Temptations can lead to considerations of pausing…

The US Food and Drug Administration has given its nod to Zepbound, a weight-loss drug now approved for obstructive sleep…

Novo Nordisk has introduced its combination drug, CagriSema, in a recent major trial to challenge Eli Lilly’s Zepbound. This long-standing…

The American Stroke Association has introduced new guidelines aimed at mitigating first-time stroke risks. These recommendations, the first update in…

Patients relying on compounded weight-loss drugs face challenges as access diminishes.With the FDA declaring an end to tirzepatide shortages, many…